P

Pionyr Immunotherapeutics

64 employees

Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Myeloid Biology
Translational Research
Therapeutics
Myeloid Tuning
Medical
Pharmaceutical
Immuno-oncology

Date founded

2015

Funding rounds raised

Total raised

$275M

from 11 investors over 11 rounds

P

Pionyr Immunotherapeutics raised $275M on June 23, 2020

Investors: Gilead Sciences

P

Pionyr Immunotherapeutics raised $62M on December 13, 2017

Investors: OrbiMed Advisors, Vida Ventures, LLC, Mission Bay Capital, Osage University Partners (OUP), Sofinnova Ventures, Russia technology fund and QB3

P

Pionyr Immunotherapeutics raised $8M on January 4, 2017

Investors: OrbiMed Advisors, Osage University Partners (OUP), Mission Bay Capital and Mission BioCapital

FAQ